GENIUROS

Medicine & Life Sciences

1. Primary Ovarian Insufficiency 100%
2. Genes 88%
3. Mutation 85%
4. High-Throughput Nucleotide Sequencing 61%
5. Pharmacogenomic Testing 56%
6. Colombia 46%
7. Clopidogrel 44%
8. Exome 42%
9. Pharmacogenetics 42%
10. Phenotype 41%
11. Whole Exome Sequencing 38%
12. Drug-Related Side Effects and Adverse Reactions 37%
13. Population 35%
14. Attention Deficit Disorder with Hyperactivity 29%
15. Vitamin B Complex 26%
16. Genome-Wide Association Study 23%
17. Alleles 23%
18. Pharmaceutical Preparations 22%
19. Acute Coronary Syndrome 22%
20. Cytochrome P-450 CYP2C19 21%
21. Population Genetics 21%
22. Missense Mutation 20%
23. Warfarin 20%
24. Quantitative Trait Loci 19%
25. Cytochrome P-450 CYP2C9 19%
26. Vitamin B 12 19%
27. Habitual Abortion 18%
28. Computational Biology 18%
29. Genomics 18%
30. Single Nucleotide Polymorphism 18%
31. Thiamine 18%
32. Therapeutics 17%
33. Exons 15%
34. Colorectal Neoplasms 15%
35. Genetic Association Studies 15%
36. Pyridoxine 15%
37. Pregnancy 15%
38. Meta-Analysis 15%
39. Pre-Eclampsia 14%
40. Fabry Disease 14%
41. Ebstein Anomaly 14%
42. Blood Platelets 13%
43. X Chromosome 13%
44. Rosuvastatin Calcium 13%
45. SARS Virus 13%
46. Apraxias 13%
47. Gene Frequency 13%
48. Platelet Aggregation Inhibitors 13%
49. Stevens-Johnson Syndrome 12%
50. Duchenne Muscular Dystrophy 12%
51. Neuromuscular Blockade 12%
52. Rhabdomyolysis 12%
53. Immunotherapy 11%
54. Dystrophin 11%
55. Ataxia 11%
56. Transcription Factors 11%
57. Proteins 11%
58. Phenytoin 11%
59. Spontaneous Abortion 11%
60. Precision Medicine 11%
61. Electrocardiography 11%
62. Forkhead Transcription Factors 10%
63. Cardiomegaly 10%
64. cyanocobalamin, pyridoxine, thiamine drug combination 10%
65. Familial premature ovarian failure 10%
66. Vitamin B 6 10%
67. Peripheral Nervous System Diseases 9%
68. Pain 9%
69. Medical Students 9%
70. Genome 9%
71. Lupus Coagulation Inhibitor 9%
72. Point Mutation 9%
73. Ceroid Lipofuscinosis, Neuronal, 6 9%
74. Ichthyosis 9%
75. Sequence Analysis 9%
76. Eye 9%
77. Biomarkers 8%
78. Infertility 8%
79. Pathology 8%
80. origen 8%
81. Kounis Syndrome 8%
82. Fucosidosis 8%
83. Congenital Pain Insensitivity 8%
84. Dissection 8%
85. Self Medication 8%
86. LEOPARD Syndrome 8%
87. RNA Splice Sites 8%
88. Primary Hypertrophic Osteoarthropathy 8%
89. Pandemics 8%
90. MicroRNAs 8%
91. Pharmacovigilance 8%
92. Pharmacokinetics 8%
93. Non-Receptor Type 11 Protein Tyrosine Phosphatase 8%
94. Costs and Cost Analysis 8%
95. Long QT Syndrome 8%
96. MutS Proteins 7%
97. Mammalian Chromosomes 7%
98. Pharmacogenomic Variants 7%
99. Molecular Biology 7%
100. Anesthesia 7%